Home > News > INTEGRA strides along the path towards net zero
Industry Updates New Products Supplier News Upcoming Events business web

INTEGRA strides along the path towards net zero

Hits:16   Date: 7/28/2026
INTEGRA Biosciences has made significant inroads towards its net zero goals in the 3 years since it committed to the Science Based Targets initiative (SBTi). This scheme provides independent assessment and approval of companies' carbon reduction targets according to strict criteria, and has been crucial in guiding the company's progress in reducing greenhouse gas emissions.
 
Infographic showing INTEGRA's emissions reduction targets.
INTEGRA's emissions reduction targets.
 
INTEGRA has been working in partnership with a leading climate protection organization, the myclimate foundation, to calculate its carbon footprint and implement practices to reduce carbon emissions. These actions have enabled the company to make great strides towards greener practices, including:
 
  • In-house generation of 970 MWh of photovoltaic electricity per year 
  • Increasing the use of renewable energy from 48 to 98 % since 2021 
  • 28 % reduction in Scope 3 emissions per turnover, notably by halving the volume of air freight, material savings on pipette tip boxes (50 %) and supporting e-mobility via company-owned charging stations
 
To achieve higher scores in the My Green Lab® ACT® Ecolabel program and provide more transparency for its customers, INTEGRA has also looked at product carbon footprints and holds gold status for its AUTO racks – currently the highest score in the tips for automation category.*
 
Visit the INTEGRA Biosciences website to learn more about the company's initiatives and future plans.
 
* May 2026
 
About INTEGRA Biosciences
INTEGRA Biosciences (www.integra-biosciences.com) is a leading provider of high-quality laboratory tools and consumables for liquid handling. The company is committed to creating innovative solutions which fulfil the needs of its customers in research, diagnostics and quality control within the life sciences markets and medical sector. INTEGRA's portfolio also encompasses next-generation sequencing (NGS) solutions, with automated workflows and magnetic bead-based reagents for reliable NGS sample preparation. INTEGRA's engineering and production teams in Zizers, Switzerland and Hudson, NH, USA, strive to develop and manufacture instruments and consumables of outstanding quality. Today, INTEGRA's innovative laboratory products are widely used all around the world where they help scientists accelerate scientific discovery. INTEGRA is an ISO 9001 certified company.
INTEGRA Biosciences AG
Tel:+41(0)81 286 95 30 (main)
E-mail:info@integra-biosciences.com